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Abstract
Hemophilia A is a X-linked hereditary condi-
tion that lead to decreased factor VIII activity,
occurs mainly in males. Decreased factor VIII
activity leads to increased risk of bleeding
events. During neonatal period, diagnosis is
made after post-partum bleeding complication
or unexpected bleeding after medical proce-
dures. Subgaleal hemorrhage during neonatal
period is a rare, severe extracranial bleeding
with high mortality and usually related to trau-
matic labor or coagulation disorders. Subgaleal
hemorrhage complications result from mas-
sive bleeding. We present a neonate with unre-
markable family history and uneventful preg-
nancy with a vaginal delivery with no instru-
mentation, presenting with severe subgaleal
bleeding at 52 hours of life. Aggressive support
measures were implemented and bleeding
managed. The unexpected bleeding lead to a
coagulation study and the diagnosis of severe
hemophilia A. There were no known sequelae.
This case shows a rare hemophilia presenta-
tion reflecting the importance of coagulation
studies when faced with unexplained severe
bleeding. 
Introduction
Hemophilia is an hereditary coagulopathy
linked to X-chromosome which mainly affects
male individuals.1 It can be either hemophilia
A or B depending whether there is a decrease
of factor VIII or IX. It has an incidence of 1 per
5000 male births.2 Hemophilia A is the most
common type accounting for 85% of the cases.2
It is suspected by an unexpected bleeding
event with isolated prolonged activated partial
thromboplastin time (APTT) on coagulation
studies.3 The diagnosis is made by decreased
plasmatic factor VIII or IX activity, after testing
other coagulation factors (including von
Willebrand factor).4 Its severity depends on the
factor activity and correlates with clinical fea-
tures, being severe hemophilia a significant
risk for spontaneous bleeding,2 and cranial
hemorrhage (3.5 to 4% of hemophilic
patients).5 After diagnosis of hemophilia,
treatment for acute bleeding should be under-
taken urgently with FVIII or FIX concentrates.
Despite being an hereditary condition it has a
significant rate of de novo mutations, which
could go from 30 to 50%.1,6 Nowadays, major
hemophilia problems are life-threatening
bleeding and inhibitor development.7
When there is known family history, usually
the diagnosis is made during the neonatal
period.8 A significant hemostatic challenge
like surgery, major trauma or labor, can repre-
sent a high bleeding risk.6,9,10 Neonatal hemo-
philia presentation is usually either related to
a traumatic labor (intracranial hemorrhage
and cephalohematoma) or to iatrogenic bleed-
ing during heel stab sampling, venous punc-
ture or vitamin K administration.3 Rarely
neonatal hemophilia presents with subgaleal
hemorrhage and it carries a high mortality risk
due to severe bleeding.11 Hemophilic patients
may remain undiagnosed during neonatal
period.6 Better treatment strategies centered
on recombinant factors replacement lead to a
considerable decrease on mortality rates for
hemophilia in last years, with recent studies
showing a nearly normal life expectancy even
in severe hemophilia.12,13 Our aim is to
describe an unknown severe hemophilia in a
neonate presenting a subgaleal hemorrhage. 
Case Report
Male, black newborn, with healthy and unre-
lated parents, and no known hereditary or
hematological conditions. All obstetric workup
was normal. The current gestation was uncom-
plicated, with a vaginal delivery at 39 weeks,
with no complications. At first exam he had an
Apgar index of 9 at first minute and 10 at five
minutes. Birth weight of 3840 grams (heavy
for gestational age), height: 50.5 cm and head
circumference: 35 cm. No dimorphism detect-
ed and there were no traumatic lesions. He
was transferred with his mother to obstetrics
ward for regular neonatal care. Vitamin K was
administered at birth and breastfeeding was
started. At 52 hours of life he was urgently
assessed for marked pallor and severe palpe-
bral edema. At physical examination he pre-
sented with scarcely active, with low pitched
crying, poor perfusion, heart rate of 135 bpp,
normal blood pressure (81/47 mmHg), normal
oxygen saturation, with normal pulmonary and
cardiac examination. He had marked irregular
scalp edema with a retro auricular hematoma.
There was a 4 cm increase on head circumfer-
ence (39 cm). There were no other changes on
physical examination, namely signs of hemor-
rhagic diathesis. No history of trauma or fall.
He was transferred to neonatal intensive care
unit and a full blood count, coagulation study,
blood chemistry and blood culture were per-
formed. The blood count was consistent with
severe anemia (hemoglobin: 6.6 g/dL) and
coagulation studies revealed a prolonged APTT
and a pro-thrombin time not coagulable, inter-
preted as an inadequate sample which was
repeated to show an isolated prolonged APTT.
Factor VIII, IX, XIII and vWF were measured,
with a very low factor VIII activity (<1%) which
was compatible with severe hemophilia. Blood
chemistry was unremarkable at first with a
steady increase in indirect bilirubin. 
Cerebral ultrasound at day 1 showed
enlarged pericerebral space, with a bad differ-
entiation of structures, with no apparent
intracranial hemorrhage. Head computed
tomography (CT) scan showed extensive bilat-
eral subgaleal hematomas and no images com-
patible with intracranial bleeding. It also
showed no signs of cranial fractures.
Meantime he started saline bolus (20 mL/kg),
erythrocyte transfusion (15 mL/kg), intra-
venous vitamin K and adequate analgesia.  
After the diagnosis, recombinant factor VIII
concentrate (50 IU/Kg) was started. There was
no further progression of the subgaleal bleed-
ing with slow decrease in head circumference.
He kept hemodynamic and cardio-respiratory
stability. He was under phototherapy for jaun-
dice during 72 hours (maximum of 18.4 mg/dL
total bilirubin).
He was discharged on day 11 of life with a
resolving subgaleal hemorrhage, head circum-
ference of 36.8 cm. He was referred to both
neonatology and hematology follow up clinics.
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Since discharge he had 2 minor bleeding
episodes (thoracic wall and right knee subcu-
taneous hematomas) requiring a single dose
of factor VIII at each event. He will start FVIII
prophylaxis after the first hemarthroses.
Currently he is 8 months old and had no fur-
ther clinical relevant complications up to date. 
Discussion
This case shows a severe subgaleal hemor-
rhage as a presentation of a severe hemophil-
ia. Despite hemophilia being a known risk fac-
tor for cranial bleeding, we found no record of
a similar presentation after an uncomplicated
vaginal delivery and with no traumatic history
or family history of coagulopathy. Our patient
presented with anemia, lethargy and pre-
shock, the most common presentation in
hemophilic patients with cranial bleeding.5 He
had a severe subgaleal hemorrhage with an
increase in 4 cm on head circumference and
jaundice and required a saline bolus and
packed red cells transfusion.14 According to
Plauché et al., 1 cm increase on head size can
relate to at least 40 mL bleeding.15,16 If we bare
in mind that the total circulating blood of a
neonate is around 80 mL/kg a 4 cm increase on
head size represents at least a blood loss of 160
mL bleed (52% of total volume).17 According to
literature, coagulation studies should be made
as soon as possible under a suspicion of con-
sumption coagulopathy.18 When present, dis-
seminated intravascular coagulopathy seems
to represent a sign of poor prognosis.19
We focused our approach on aggressive cor-
rection of hypovolemic shock with saline bolus
and red cell transfusion, according to the exis-
tent literature.20 Inotropes and vasopressors
may also be used. 
High mortality rates of subgaleal hemor-
rhage are related to delays on diagnosis, mis-
diagnosis and inadequate monitoring and
treatment.18 So early recognition, careful mon-
itoring and aggressive treatment were impor-
tant to improve outcome.
As recommended by literature head imaging
with a CT scan was made as soon as possible
to assess the size of bleeding and related com-
plications or co-morbidities.18 Head magnetic
resonance would be the preferred imaging
method,18 but was not promptly available. 
Complications related to subgaleal hemor-
rhage and hypoxic ischemic encephalopathy
can complicate up to 72% of the cases.14
Development delay and cerebral palsy are the
main complications,18 however outcome of sur-
vivors is usually good, with a maximum
described disability incidence of 33%.19 At this
moment our patient shows a normal develop-
ment. 
In severe hemophilia, the prevention of
bleeding by prophylactic therapy is now advo-
cated. The optimal treatment regimen for pro-
phylaxis is debatable (when to start and which
dose). Long term treatment strategies for
hemophilia vary, with more studies suggesting
a prophylactic treatment for severe cases of
hemophilia A and an on demand treatment
should be considered for mild and moderate
cases.4 Most of these studies are not conducted
on neonates and small children for whom
there is scarce information about the ideal
treatment plan. According to the hematology
department we decided to maintain our patient
with on demand treatment, until the first
hemarthroses.
Conclusions
After reviewing existent literature we con-
clude that our patient had a rare presentation
of hemophilia. He presented a subgaleal hem-
orrhage after an uncomplicated vaginal deliv-
ery. Aggressive support treatment was effec-
tive on controlling initial bleeding and prevent-
ing shock. Hemophilia diagnosis was made
within 12 hours after presentation and treat-
ment towards hemophilia A started, with no
other bleeding episodes during inpatient stay.
Imaging studies showed no other complica-
tions from the initial presentation and a nor-
mal neurodevelopment was achieved up to
date. This case report reminds that hemophilia
can present in several different ways. When
facing a significant bleeding on a neonate with
no risk factors, a blood coagulation disorder
must be thought along with immediate aggres-
sive support measures. An early diagnosis
allows to an early directed treatment and bet-
ter outcome.
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